New ways to assess lymph nodes in cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This trial compares three methods (LN-RADS, RECIST 1.1, and Node-RADS) to see which best evaluates lymph nodes in people with cancer. It may help doctors make more accurate decisions about your lymph nodes using CT or MRI scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer or your doctor suspects you may have cancer.
- You are scheduled for a biopsy or surgery to remove lymph nodes, or you already have plans for such a procedure.
- You have had or will have a CT or MRI scan that includes the area where your lymph nodes are located.
- Your cancer diagnosis has been confirmed by a tissue sample (biopsy) or cell sample.
- You agree to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses multiple ultrasound methods to check the lymph nodes under the arm in people newly diagnosed with breast cancer. It aims to better understand the spread of cancer before surgery.
This trial looks at how much the lymph nodes respond to chemoradiation before surgery in people with locally advanced rectal cancer. It aims to understand if that response can predict long-term results and guide future treatment choices.
This trial studies a better way to remove and examine lymph nodes from lung cancer surgery specimens. It aims to improve how doctors check for cancer spread, which may help guide your treatment after surgery.
This study uses a special MRI scanner in the operating room to help guide lymph node removal during surgery for urologic cancers like bladder, prostate, testicular, kidney, urethral, or penile cancer. It aims to see if this real-time imaging can make the surgery more precise.
This study uses images of your removed lymph nodes to see if cancer has spread there. It may help doctors better understand your cancer without needing extra tests.
This trial uses MRI scans to predict if breast cancer has spread to additional lymph nodes beyond the first one that was biopsied. It may help women who have already had a positive sentinel lymph node biopsy and then had more lymph nodes removed.
Hear when a new Lymph Node Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.